TBC1D5 reverses the capability of HIF-2α in tumor progression and lipid metabolism in clear cell renal cell carcinoma by regulating the autophagy

MLA

Yu Huang, et al. “TBC1D5 Reverses the Capability of HIF-2α in Tumor Progression and Lipid Metabolism in Clear Cell Renal Cell Carcinoma by Regulating the Autophagy.” Journal of Translational Medicine, vol. 22, no. 1, Feb. 2024, pp. 1–20. EBSCOhost, https://doi.org/10.1186/s12967-024-05015-y.

APA

Yu Huang, Zhiyong Xiong, Jianjun Wang, Yafen Gao, Qi Cao, Decai Wang, Jian Shi, Zhixian Chen, & Xiong Yang. (2024). TBC1D5 reverses the capability of HIF-2α in tumor progression and lipid metabolism in clear cell renal cell carcinoma by regulating the autophagy. Journal of Translational Medicine, 22(1), 1–20. https://doi.org/10.1186/s12967-024-05015-y

Chicago

Yu Huang, Zhiyong Xiong, Jianjun Wang, Yafen Gao, Qi Cao, Decai Wang, Jian Shi, Zhixian Chen, and Xiong Yang. 2024. “TBC1D5 Reverses the Capability of HIF-2α in Tumor Progression and Lipid Metabolism in Clear Cell Renal Cell Carcinoma by Regulating the Autophagy.” Journal of Translational Medicine 22 (1): 1–20. doi:10.1186/s12967-024-05015-y.